Rationally Engineered Therapeutic Proteins with Reduced Immunogenicity-Reference-Cited by-同舟云学术

Rationally Engineered Therapeutic Proteins with Reduced Immunogenicity

Published:2005-03-04 Issue:6 Volume:174 Page:3187-3196
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J Immunol

Author:

Tangri Shabnam,Mothé Bianca R.,Eisenbraun Julie,Sidney John,Southwood Scott,Briggs Kristen,Zinckgraf John,Bilsel Pamuk,Newman Mark,Chesnut Robert,LiCalsi Cynthia,Sette Alessandro

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference43 articles.

1. Adenovirus-Mediated Factor VIII Gene Expression Results in Attenuated Anti-Factor VIII-Specific Immunity in Hemophilia A Mice Compared with Factor VIII Protein Infusion

2. Clinical significance of antibodies against calcitonin

3. Pure Red-Cell Aplasia and Antierythropoietin Antibodies in Patients Treated with Recombinant Erythropoietin

Cited by 158 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Detection of Hepatocellular Carcinoma in an Orthotopic Patient-Derived Xenograft with an Epithelial Cell Adhesion Molecule-Specific Peptide;Cancers;2024-08-10

2. Assessing the immunogenicity risk of salmon calcitonin peptide impurities using in silico and in vitro methods;Frontiers in Pharmacology;2024-08-09

3. In silico methods for immunogenicity risk assessment and human homology screening for therapeutic antibodies;mAbs;2024-03-27

4. T and B cell epitope analysis for the immunogenicity evaluation and mitigation of antibody-based therapeutics;mAbs;2024-03-21

5. Reducing Immunogenicity by Design: Approaches to Minimize Immunogenicity of Monoclonal Antibodies;BioDrugs;2024-01-23